Acknowledgment for APICES collaboration in a Urothelial Carcinoma study

This month, we want to share the acknowledgment that APICES has received in a Urothelial Carcinoma study in the recent paper published in Clinical and Translational Oncology, in which APICES has collaborated in medical writing.

This means a great motivation to all the APICES team to give continuity to the implication we have in every project in which we collaborate. APICES is very proud of the recognition of our work, and we would like to thank Astra Zeneca Spain and Dr. César Gutiérrez for giving us the opportunity to appear in the acknowledgments of the publication and congratulate them and all the investigators for their project success.

This real-world evidence (RWE) study aimed at describing the molecular profile of a real-world cohort of patients with metastatic urothelial carcinoma (mUC) and evaluating the benefit of next-generation sequencing (NGS) panels in guiding therapy for these patients. Additionally, it assesses the outcomes of DNA-matched treatments recommended by a multidisciplinary molecular tumor board (MMTB).

You can find more information in the following link: https://link.springer.com/article/10.1007/s12094-024-03651-w